R. Egg

1.8k total citations
14 papers, 1.4k citations indexed

About

R. Egg is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, R. Egg has authored 14 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 6 papers in Rheumatology and 5 papers in Neurology. Recurrent topics in R. Egg's work include Multiple Sclerosis Research Studies (10 papers), Systemic Lupus Erythematosus Research (6 papers) and Peripheral Neuropathies and Disorders (5 papers). R. Egg is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Systemic Lupus Erythematosus Research (6 papers) and Peripheral Neuropathies and Disorders (5 papers). R. Egg collaborates with scholars based in Austria, Germany and United Kingdom. R. Egg's co-authors include Florian Deisenhammer, Thomas Berger, Markus Reindl, Erika Dilitz, Irmgard Mayringer, Hanno Ulmer, Christopher Linington, Franz Schautzer, Finn Sellebjerg and Gavin Giovannoni and has published in prestigious journals such as New England Journal of Medicine, Brain and Journal of Neuroimmunology.

In The Last Decade

R. Egg

14 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Egg Austria 13 771 479 380 287 263 14 1.4k
Siegrid Strasser‐Fuchs Austria 17 820 1.1× 406 0.8× 235 0.6× 285 1.0× 243 0.9× 32 1.5k
Mohammad K. Sharief United Kingdom 13 963 1.2× 506 1.1× 445 1.2× 351 1.2× 282 1.1× 18 1.7k
John Thorpe United Kingdom 19 1.2k 1.5× 481 1.0× 230 0.6× 338 1.2× 224 0.9× 29 1.7k
Irena Dujmović Serbia 23 1.0k 1.4× 656 1.4× 216 0.6× 389 1.4× 279 1.1× 65 1.6k
Rainer Ehling Austria 21 1.1k 1.5× 792 1.7× 293 0.8× 372 1.3× 177 0.7× 52 1.8k
Tomoko Okamoto Japan 18 655 0.8× 659 1.4× 338 0.9× 213 0.7× 636 2.4× 85 1.9k
Aaron Boster United States 22 925 1.2× 405 0.8× 183 0.5× 207 0.7× 306 1.2× 44 1.4k
Sudhakar Reddy Kalluri Germany 15 1.0k 1.3× 734 1.5× 368 1.0× 293 1.0× 344 1.3× 23 1.5k
Ludwig Kappos Switzerland 17 973 1.3× 479 1.0× 176 0.5× 242 0.8× 235 0.9× 59 1.6k
Luís Brieva Spain 21 1.0k 1.3× 791 1.7× 208 0.5× 303 1.1× 295 1.1× 77 1.8k

Countries citing papers authored by R. Egg

Since Specialization
Citations

This map shows the geographic impact of R. Egg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Egg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Egg more than expected).

Fields of papers citing papers by R. Egg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Egg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Egg. The network helps show where R. Egg may publish in the future.

Co-authorship network of co-authors of R. Egg

This figure shows the co-authorship network connecting the top 25 collaborators of R. Egg. A scholar is included among the top collaborators of R. Egg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Egg. R. Egg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Deisenhammer, Florian, R. Egg, Gavin Giovannoni, et al.. (2009). EFNS guidelines on disease‐specific CSF investigations. European Journal of Neurology. 16(6). 760–760. 57 indexed citations
2.
Gneiss, Claudia, R. Egg, Rainer Ehling, et al.. (2006). Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients. Multiple Sclerosis Journal. 12(6). 731–737. 38 indexed citations
3.
Deisenhammer, Florian, Aleš Bartoš, R. Egg, et al.. (2006). Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. European Journal of Neurology. 13(9). 913–922. 239 indexed citations
4.
Gneiss, Claudia, Rainer Ehling, Michael Khalil, et al.. (2006). Interferon-β antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies. Journal of Neuroimmunology. 174(1-2). 174–179. 15 indexed citations
5.
Lutterotti, Andreas, Bettina Kuenz, Viktoria Gredler, et al.. (2006). Increased serum levels of soluble CD14 indicate stable multiple sclerosis. Journal of Neuroimmunology. 181(1-2). 145–149. 21 indexed citations
6.
Frauscher, Birgit, R. Egg, Elisabeth Brandauer, et al.. (2005). Daytime sleepiness is not increased in mild to moderate multiple sclerosis: a pupillographic study. Sleep Medicine. 6(6). 543–547. 20 indexed citations
7.
Gneiss, Claudia, Markus Reindl, Thomas Berger, et al.. (2004). Epitope Specificity of Neutralizing Antibodies Against IFN-β. Journal of Interferon & Cytokine Research. 24(5). 283–290. 22 indexed citations
8.
Gneiss, Claudia, Markus Reindl, Andreas Lutterotti, et al.. (2004). Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity. Multiple Sclerosis Journal. 10(5). 507–510. 40 indexed citations
9.
Harvey, Jennifer, Franz Schautzer, R. Egg, et al.. (2003). A novel and rapid assay for the detection of neutralizing antibodies against interferon-beta. Multiple Sclerosis Journal. 9(1). 32–35. 11 indexed citations
10.
Berger, Thomas, Franz Schautzer, R. Egg, et al.. (2003). Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event. New England Journal of Medicine. 349(2). 139–145. 454 indexed citations
11.
Egg, R., et al.. (2002). Autonomic instability, as measured by pupillary unrest, is not associated with multiple sclerosis fatigue severity. Multiple Sclerosis Journal. 8(3). 256–260. 21 indexed citations
12.
Egg, R., Markus Reindl, Florian Deisenhammer, Christopher Linington, & Thomas Berger. (2001). Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis. Multiple Sclerosis Journal. 7(5). 285–289. 86 indexed citations
13.
Reindl, Markus, Gabriele Knipping, Erika Dilitz, et al.. (2001). Increased intrathecal production of apolipoprotein D in multiple sclerosis. Journal of Neuroimmunology. 119(2). 327–332. 59 indexed citations
14.
Reindl, Markus, Christopher Linington, Uschi Brehm, et al.. (1999). Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain. 122(11). 2047–2056. 277 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026